With the strengthening of national supervision on product quality, people pay more attention to the fairness of testing data, and the scope, items and frequency of testing are constantly expanding and increasing. Especially in recent years, product quality and safety incidents occur frequently. Consumers in China and relevant personnel of all parties hope that authoritative third-party testing institutions can test product quality, and the development of third-party testing institutions is becoming more and more important. Since its establishment in 2002, Puni Testing has been deeply involved in inspection and certification for many years. At present, the company's business has touched many fields and developed into a "general" among domestic private third-party testing institutions.
Puni Testing's main business is inspection, measurement, certification and related technical services, covering health and environmental protection, electronic and safety regulations, consumer goods quality appraisal, safety protection and other fields.
Participated in important social testing work many times.
As one of the earliest third-party inspection and testing institutions in China, Puni Testing has established a high brand awareness and social credibility in the industry after 18 years of development and accumulation.
Since the outbreak of COVID-19 epidemic in June 5438+October 20201October, Puni Testing has actively responded to and strictly implemented the regulations and requirements of national government departments on epidemic prevention and control, actively cooperated with government departments to carry out food and agricultural products safety testing and environmental emergency monitoring tasks, and actively expanded the testing business of medical devices such as masks.
Previously, Puni Testing has participated in the supervision and sampling inspection of national and local market supervision and management, agriculture and rural areas, ecological environment and other departments for many times, and provided environmental and food safety testing services for major national events such as the 2008 Beijing Olympic Games, the 20 10 Shanghai World Expo, the 20 10 Guangzhou Asian Games and the 20 14 Beijing APEC Summit.
After the nationwide melamine incident broke out in 2007, Puni Testing bravely shouldered the heavy burden and became a melamine testing institution approved by CNCA to undertake the task of dairy products testing.
From August 2065438 to August 2009, Puni detection was approved as the designated laboratory for African swine fever detection, which was used to detect African swine fever virus nucleic acid in pork, processed pork and pig feed.
In April, 2020, Puni Medical, a wholly-owned subsidiary, was approved as one of the first batch of COVID-19 nucleic acid detection units in Beijing and began to provide COVID-19 nucleic acid detection services.
For the third-party inspection and testing institutions, brand and reputation are the core competitiveness and the foundation of stable development, which need long-term accumulation and investment. Good brand and high credibility can usually make third-party inspection and testing institutions gain a favorable market competitive position.
The fundraising project depicts the blueprint for development.
Because the inspection and testing industry is capital-intensive and technology-intensive, there is a great demand for funds, so it is necessary to invest in inspection and testing equipment, establish professional laboratories and equip professionals. In order to seize the market opportunity and consolidate the competitive advantage of Puni Testing in Central China and East China, the company needs to further strengthen its inspection and testing capabilities and provide one-stop inspection and testing services for more customers. In addition to the expansion of inspection and testing capabilities, Puni Testing also pays more attention to the promotion of R&D and management capabilities to business development. The funds raised in this part will be used for the construction of the company's R&D base and operation headquarters, and the company will enhance its core competitiveness through continuous technological innovation, mature management system and data sharing mechanism.
According to the disclosure in the prospectus, after deducting the issuance expenses, all the funds raised by Puni Testing IPO will focus on the company's main business, and be invested in new production and auxiliary housing projects (Puni Testing Group East China Operation Headquarters Construction Project), Puni Testing R&D and Testing Base and Central China Operation Headquarters Construction Project, Biomedical Diagnostic Reagent R&D Center Project and Supplementary Liquidity Project. The total investment of the above projects is 994 million yuan, and the amount of funds raised by this public offering is 832 million yuan.
The new production and auxiliary building project, Puni testing R&D testing base and the construction project of Central China operation headquarters will build new laboratories, expand the company's existing business capabilities, and at the same time enhance the company's inspection and testing capabilities in the fields of automobile and electronic reliability, which is the expansion and refinement of the company's existing business. The biomedical diagnostic reagent research and development center project will effectively integrate the company's existing inspection and testing capabilities in the biomedical field, and enhance the company's diagnostic reagent research and development capabilities and overall technical level. Supplementary liquidity projects meet the needs of the company's business development for liquidity and provide support for the development of its main business.
(Editor Shen Ming)